The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years

Amblyopia Clinical Trial

— I-BiT Plus  

Official title:

The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02810847
• Other study ID #: 13OY006
• Status: Not yet recruiting
• Phase: N/A
• First received: April 26, 2016
• Last updated: June 20, 2016
• Start date: June 2016
• Est. completion date: December 2017

Study information

• Verified date: June 2016
• Source: Nottingham University Hospitals NHS Trust
• Contact: Rebecca Brown
• Phone: 0115 9249924
• Email: Rebecca.brown4[@]nuh.nhs.uk
• Is FDA regulated: No
• Health authority: United Kingdom: Medicines and Healthcare Products Regulatory AgencyUnited Kingdom: Research Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Around one child in fifty has a lazy eye (termed amblyopia) where the eye is structurally normal but the vision fails to develop correctly. Around half of these children also have a squint (strabismus) where each eye has a different direction of gaze. This condition is the commonest cause of visual impairment in one eye in children.

This is a randomised control trial of wearing glasses alone (which will result in some visual improvement, termed refractive adaptation) and wearing glasses combined with using I-BiT Plus.

The hypothesis is that using I-BiT Plus will result in an improved visual outcome.

Description:

This study will treat amblyopia (lazy eye) using 3-D computer technology and active shutter glasses. Computer games and DVD's are viewed through the active shutter glasses and are specially prepared to preferentially stimulate the lazy eye; the child can only play the games accurately if they are using their lazy eye. The study is funded by the NIHR and will be undertaken as a randomised control trial to compare this against normal computer games and DVD viewing combined with continuing refractive adaptation (a process that is known to occur for up to 30 weeks). Patients will receive 6 weeks of treatment (recommended 30 mins minimum of play time per day for 6 weeks in the treatment arm) and level of vision will be assessed after 6 weeks and the visual improvement (they will be wearing glasses and also undergoing refractive adaptation) compared with the control. Patients will return to standard care after the trial period which, at 6 weeks, should not affect the final visual outcome in a negative way. The participants will be recruited from patients currently attending one of the 4 trial sites and will have a diagnosis of amblyopia, and be aged between 3 years 6 months and 9 years 11 months. Current treatments for amblyopia include wearing an eye patch over the good eye for up to 6 hours per day, or using eye drops to blur the image in the good eye for periods of 4 weeks at a time. The aim is both to avoid the need for patching or penalisation (which are unpopular treatments) and to get an improved visual outcome.

Assessment study: A study on 62 patients where the investigators will compare the visual acuity, angle of strabismus, stereoacuity and depth of suppression as estimated by I-BiT against measurements made at orthoptic assessment. This data will help interpret the results of the randomised controlled trial and help direct future development.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 182
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 42 Months to 9 Years

Eligibility

Inclusion Criteria:

• The child must be aged between 3 years 6 months and 9 years 11 months (upper limit is one day before their 10th birthday on day of consent.)

• Visual acuity difference of at least 0.3 log units, with the amblyopic eye being 0.3 logMAR or worse.

• Must have undergone a minimum of 12 weeks refractive adaptation.

• Those in group one must not have had patching or penalisation at all previously but the other two groups' participants may have had previous occlusion.

• Must not have had previous strabismus surgery (for groups one and two, and for group three, they must start the treatment within 4 weeks of having surgery.

• Must be able to use the I-BiT plus system.

Exclusion Criteria:

• Stimulus deprivation amblyopia.

• Other ocular or neurological disease affecting the visual system (including Down's syndrome, developmental delay,Craniofacial syndrome,Foetal Alcohol Syndrome, and cerebral palsy among other conditions).

• Photosensitive epilepsy.

• Parent, guardian or child not prepared to give consent.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Amblyopia
• Strabismus

Intervention

Device:
• I-Bit plus
The study will treat amblyopia (lazy eye) using 3-D computer technology and active shutter glasses. Computer games and DVD's are viewed through the active shutter glasses and are specially prepared to preferentially stimulate the lazy eye; the child can only play the game accurately if they are using their lazy eye.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
Nottingham University Hospitals NHS Trust	National Institute for Health Research, United Kingdom, Wellcome Trust

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The change of visual acuity from baseline to week six post randomisation visit between the two arms in each group.		6 weeks	No
Secondary	Successful delivery and installation of equipment to patients' homes, and any reasons for failure		10 weeks	No
Secondary	The ability of the patients to use the equipment in their home (unsupervised) setting and any reasons why not. Ocular alignment Stereoacuity Proportion of patients completing course		10 weeks	No
Secondary	The time taken by the patients to use the equipment in their home (unsupervised) setting.		10 weeks	No
Secondary	The robustness of the equipment by measuring failure / breakage rate.		10 weeks	No
Secondary	Completeness of outcome measures will be assessed via the frequency of missing data.		10 weeks	No
Secondary	The recruitment rate and reasons for not taking part.		10 weeks	No
Secondary	The retention rate and reasons for drop out.		10 weeks	No
Secondary	Any problems encountered with the randomisation process.		10 weeks	No
Secondary	The standard deviation in visual acuity at 6 weeks; this will inform sample size calculations for a future trial to assess effectiveness of the I-BiT™ system.		6 weeks	No
Secondary	Change in visual acuity in the amblyopic eye from baseline to weeks 3 and 10 post randomisation between the two arms.		8 Weeks	No
Secondary	Change in stereoacuity from baseline to week 3 post randomisation between the two arms.		3 weeks	No
Secondary	Change in stereoacuity from week 3 to weeks 6 and 10 for the I-BiT treated groups.		8 Weeks	No
Secondary	Change in binocular status and ocular alignment from baseline to week 6 post randomisation between the two arms in each group.		6 Weeks	No
Secondary	Change in binocular status and ocular alignment from week 6 to week 10 for the I-BiT treated groups.		5 weeks	No
Secondary	Quality of life questionnaire at week 6.		6 weeks	No
Secondary	Proportion of patients completing course of treatment (defined as minimum of 18 hours in total, which equates to 30 minutes per day 6 days per week for six weeks).		18 hours	No
Secondary	The change in visual acuity, and angle of strabismus between weeks 3, 6 and 10 for the I-BiT treated groups.		8 weeks	No